Search

Your search keyword '"E Massie"' showing total 195 results

Search Constraints

Start Over You searched for: Author "E Massie" Remove constraint Author: "E Massie"
195 results on '"E Massie"'

Search Results

1. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study

2. The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

3. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

4. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

6. Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer

7. Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer

8. Supplementary Table 1 from Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models

9. Supplementary Data from Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models

10. Data from Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models

11. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

12. 294 Implementation of Colorectal Robotic Assisted Surgical Programme During a Global Pandemic: Collaboration Between Territorial and National Waiting Times Centre

13. Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study

14. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

15. Nitrogen partitioning between branched-chain amino acids and urea cycle enzymes sustains renal cancer progression

16. PD49-04 ACCURATE DIFFERENTIATION OF PATHOLOGICAL SUBTYPES OF RENAL TUMOUR BY APPLYING A MACHINE LEARNING MODEL TO EPIGENETIC MARKERS

17. ctDNA detection by personalised assays in early-stage NSCLC

18. Elective cancer surgery in COVID-19–Free surgical pathways during the SARS-cov-2 pandemic: An international, multicenter, comparative cohort study

19. Development of a DNA Methylation–Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma

20. ctDNA monitoring using patient-specific sequencing and integration of variant reads

21. Machine Classification of Methylomes in Cancer

23. Post-Release Evaluation of Diaphorencyrtus aligarhensis (Hymenoptera: Encyrtidae) and Tamarixia radiata (Hymenoptera: Eulophidae) for Biological Control of Diaphorina citri (Hemiptera: Liviidae) in Urban California, USA

24. Implementing liquid biopsies into clinical decision making for cancer immunotherapy

25. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

26. Independence of HIF1a and androgen signaling pathways in prostate cancer

27. High-sensitivity monitoring of ctDNA by patient-specific sequencing panels and integration of variant reads

28. Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours

29. HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E2F1‐mediated cell cycle network

30. LBA-14 COMPREHENSIVE CHARACTERISATION OF CIRCULATING TUMOUR DNA IN PLASMA AND URINE OF PATIENTS WITH RENAL TUMOURS: RESULTS OF THE DIAMOND AND MONREC STUDIES

31. Using prognosis to guide early detection and treatment selection in non-metastatic prostate cancer

32. Density dependent mortality, climate, and Argentine ants affect population dynamics of an invasive citrus pest, Diaphorina citri, and its specialist parasitoid, Tamarixia radiata, in Southern California, USA

33. Accurate differentiation of renal tumour pathological subtypes using a machine learning model of epigenetic markers

34. Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel

35. Abstract 736: ctDNA detection in early stage non-small cell lung cancer

36. Enhanced detection of circulating tumor DNA by fragment size analysis

37. Classification and Personalized Prognosis in Myeloproliferative Neoplasms

38. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

39. PD60-02 DISCOVERY AND VALIDATION OF A NOVEL FLUID BIOMARKER FOR THE DIAGNOSIS AND RISK STRATIFICATION OF PROSTATE CANCER

40. PD56-03 DETECTION OF PRIVATE CLONAL MUTATIONS IN LOCALISED PROSTATE CANCER FROM RARE MOLECULES OF CIRCULATING TUMOUR DNA

41. Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models

42. The role of TET-mediated DNA hydroxymethylation in prostate cancer

43. CVE: an R package for interactive variant prioritisation in precision oncology

44. Selecting short DNA fragments in plasma improves detection of circulating tumour DNA

45. The transcriptional programme of the androgen receptor (AR) in prostate cancer

46. Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress

47. The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man

48. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

49. JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response

50. Methods to Identify Chromatin-Bound Protein Complexes: From Genome-Wide to Locus-Specific Approaches

Catalog

Books, media, physical & digital resources